Alzheimer

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved lecanemab, a new Alzheimer’s drug designed to slow cognitive decline in patients with the disease. This marks the first …

An experimental drug from Eli Lilly LLY.N works best if Alzheimer’s patients are treated as early as possible, ideally before they develop symptoms of the brain-wasting disease, researchers said on …